Sorry, CAT- I am getting captcha'd for long posts so here is my reply..sorry for the poor guy and you two, too.

Likely just the original, or close...this from June? last year..

Extrapulmonary manifestations of COVID-19
[link to www.nature.com (secure)]
Although COVID-19 is most well known for causing substantial respiratory pathology, it can also result in several extrapulmonary manifestations. These conditions include thrombotic complications, myocardial dysfunction and arrhythmia, acute coronary syndromes, acute kidney injury, gastrointestinal symptoms, hepatocellular injury, hyperglycemia and ketosis, neurologic illnesses, ocular symptoms, and dermatologic complications. Given that ACE2, the entry receptor for the causative coronavirus SARS-CoV-2, is expressed in multiple extrapulmonary tissues, direct viral tissue damage is a plausible mechanism of injury. In addition, endothelial damage and thromboinflammation, dysregulation of immune responses, and maladaptation of ACE2-related pathways might all contribute to these extrapulmonary manifestations of COVID-19.

There's also the fact that like malaria it affects CD147 which malaria parasite uses to invade red blood cells (erythrocytes).

PS - afaik Ivermectin is effective on ALL strains so far and other viruses too. Works two ways to stop infection and raw-material access.